MedTrace Logo

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

NCT05862649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-04-21

No results posted yet for this study

Summary

This is a multicenter longitudinal study in about 300 patients with Idiopathic Parkinson's disease, who will be evaluated in several clinical centers with a clinical assessment and an oculometric examination during a time period with specific intervals. This study aims to evaluate the correlation between oculometric measures and clinical assessment over time, as well as the potential to detect early change in clinical status using an oculometric assessment.

Conditions

  • Parkinson Disease

Interventions

OTHER

NeuraLight

NeuraLight software-based platform

Sponsors & Collaborators

  • European Clinical Research Infrastructure Network

    collaborator OTHER

  • NeuraLight

    lead INDUSTRY

Principal Investigators

  • Christina Januário, MD · University of Coimbra

  • Richard Armstrong, MD · The VCTC

  • Pablo Mir, MD · Instituto de Biomedicina de Sevilla (IBiS

  • Michelle Tosin, PhD · Rush Medical University Center

  • Bettina Balint, MD · University Hospital, Zürich

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-21
Primary Completion
2026-03-02
Completion
2026-03-02

Countries

  • United States
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862649 on ClinicalTrials.gov